NewsBenzingaBiohaven 在 ENA 2026 上展示了 BHV-1530 持续进行的 1 期研究临床数据;BHV-1530 是一种潜在的靶向 FGFR3 的 ADC,携带拓扑异构酶 I 载荷 Biohaven 在 ENA 2026 上展示了 BHV-1530 持续进行的 1 期研究临床数据;BHV-1530 是一种潜在的靶向 FGFR3 的 ADC,携带拓扑异构酶 I 载荷 Benzinga 2026.11.19 12:35 (GMT+0) Open on Benzinga Other news T. Rowe Price Group Stock: Is Wall Street Bullish or Bearish? Data: Anthropic Enters 82 ETFs on First Trading Day With About $84 Billion in Volume Ahead of Sidus Space Earnings, Here's What Barchart Data Says Comes Next for SIDU Stock Six AI-powered gadgets that could make your home office smarter Nvidia Set for Seventh Straight Weekly Drop, Longest Losing Streak Since 2008 Dover Stock: Analyst Estimates & Ratings